Imaging Mitochondrial Complex-I in Alcohol Use Disorder
for Alcohol Use Disorder (AUD)
1 location in Pittsburgh
Sponsor: Rajesh Narendran
Sex: All·Age: 18 - 55·Accepts healthy volunteers
Code: NCT07825818·EARLY_Phase 1·Recruiting·Listed Sep 17, 2026
Paid Clinical Trials in Pittsburgh, PA
As of September 2026, 1,240 paid clinical trials are recruiting in Pittsburgh, Pennsylvania. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Pittsburgh offers studies at sites including University of Pittsburgh for conditions such as Breast Cancer, Ovarian Cancer, Endometrial Cancer, Stroke. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Pittsburgh
Trials by drug in Pittsburgh
Filter results
Filter results
Newly added in Pittsburgh
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors
for Selected Advanced Solid Tumors
Sites in Pittsburgh +1 more location
Sponsor: SK Life Science, Inc.
Sex: All·Age: 18+
Code: NCT07812805·Phase 1·Recruiting·Listed Sep 10, 2026
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
for Heart Failure With Preserved Ejection Fraction
Sites in Pittsburgh, Mechanicsburg +23 more locations
Sponsor: Edgewise Therapeutics, Inc.
Sex: All·Age: 30 - 84
Code: NCT07795814·Phase 2·Recruiting·Listed Aug 31, 2026
Imaging Mitochondrial Complex-I in Cocaine Use Disorder: a [F-18]BCPP-EF PET Study
for Cocaine Use Disorder
1 location in Pittsburgh
Sponsor: Rajesh Narendran
Sex: All·Age: 18 - 45·Accepts healthy volunteers
Code: NCT07773649·EARLY_Phase 1·Recruiting·Listed Aug 19, 2026
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
for Type 2 Diabetes
Drug: Survodutide
Sites in Pittsburgh, Beaver +87 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT07754461·Phase 3·Recruiting·Listed Aug 10, 2026
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
for Obesity
Sites in Pittsburgh, Philadelphia +82 more locations
Sponsor: Ascletis Pharma (China) Co., Limited
Sex: All·Age: 18+
Code: NCT07743450·Phase 3·Recruiting·Listed Aug 3, 2026
1,099 clinical trials
Get a weekly email when new trials open in Pittsburgh, PA.
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
for Migraine
Drug: Elismetrep
Sites in Pittsburgh, Scottdale +111 more locations
Sponsor: Kallyope Inc.
Sex: All·Age: 18 - 75
Code: NCT07645924·Phase 3·Recruiting·Listed Jun 2026
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
for Pneumococcal Disease
Sites in Pittsburgh, Cranberry Township +104 more locations
Sponsor: Pfizer
Sex: All·Age: 42 Days - 211 Days·Accepts healthy volunteers
Code: NCT07629440·Phase 3·Recruiting·Listed Jun 2026
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
for Atopic Dermatitis
Sites in Pittsburgh, Camp Hill +31 more locations
Sponsor: Apollo Therapeutics Ltd
Sex: All·Age: 18 - 65
Code: NCT07599813·Phase 2·Recruiting·Listed May 2026
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
for Cardiovascular Disease and Lipoprotein(a)
Drug: Pelacarsen
Sites in Pittsburgh, Lancaster +99 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18 - 100
Code: NCT07517263·Phase 3·Recruiting·Listed Apr 2026
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
for Solid Tumors
Drug: INCB161734
Sites in Pittsburgh, Philadelphia +67 more locations
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT07522073·Phase 3·Recruiting·Listed Apr 2026
Phase 2 Study to Assess the Safety and Efficacy of ANG003
for Exocrine Pancreatic Insufficiency (EPI)
Sites in Pittsburgh, Hershey +25 more locations
Sponsor: Anagram Therapeutics, Inc.
Sex: All·Age: 12+
Code: NCT07450547·Phase 2·Recruiting·Listed Mar 2026
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
for Overweight
Drug: Eloralintide
Sites in Pittsburgh +58 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07392190·Phase 3·Recruiting·Listed Feb 2026
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
for Hepatitis
Drug: Larsucosterol
Sites in Pittsburgh, Hershey +83 more locations
Sponsor: Bausch Health Americas, Inc.
Sex: All·Age: 18+
Code: NCT07428538·Phase 3·Recruiting·Listed Feb 2026
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
for Pancreatic Cancer
Sites in Pittsburgh +48 more locations
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All·Age: 18+
Code: NCT07409272·Phase 3·Recruiting·Listed Feb 2026
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
for Obesity or Overweight
Drug: Enicepatide
Sites in Pittsburgh +41 more locations
Sponsor: Hoffmann-La Roche
Sex: All·Age: 18+
Code: NCT07351058·Phase 3·Recruiting·Listed Jan 2026
A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
for Adenovirus Infections
Sites in Pittsburgh, Philadelphia +30 more locations
Sponsor: SymBio Pharmaceuticals
Sex: All·Age: 2 Months+
Code: NCT07387367·Phase 3·Recruiting·Listed Feb 2026
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
for Non-Small Cell Lung Cancer (NSCLC)
Drug: Pumitamig
Sites in Pittsburgh, York +39 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT07361510·Phase 3·Recruiting·Listed Jan 2026
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
for Overweight
Drug: Eloralintide
Sites in Pittsburgh, Uniontown +58 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07282600·Phase 3·Recruiting·Listed Dec 2025
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
for CRC (Colorectal Cancer)
Drug: Bevacizumab
Sites in Pittsburgh, York +73 more locations
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT07284849·Phase 3·Recruiting·Listed Dec 2025
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
for Pancreatic Cancer
Drug: daraxonrasib
Sites in Pittsburgh, Philadelphia +41 more locations
Sponsor: Revolution Medicines, Inc.
Sex: All·Age: 18+
Code: NCT07252232·Phase 3·Recruiting·Listed Nov 2025
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
for Untreated, Unresectable, or Metastatic Colorectal Cancer
Drug: Bevacizumab
Sites in Pittsburgh, Allentown +42 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT07221357·Phase 2, Phase 3·Recruiting·Listed Oct 2025
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
for Overweight
Sites in Pittsburgh +33 more locations
Sponsor: Novo Nordisk A/S
Sex: All·Age: 8 - 18
Code: NCT07253285·Phase 3·Recruiting·Listed Nov 2025
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
for Prostatic Neoplasms, Castration-Resistant
Drug: Pasritamig
Sites in Pittsburgh, Hershey +51 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07225946·Phase 3·Recruiting·Listed Nov 2025
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
for Atopic Dermatitis
Sites in Pittsburgh +45 more locations
Sponsor: Sanofi
Sex: All·Age: 12+
Code: NCT07290803·Recruiting·Listed Dec 2025
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
for Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Drug: Nivolumab
Sites in Pittsburgh +33 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT07221149·Phase 2, Phase 3·Recruiting·Listed Oct 2025
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
for Carcinoma, Transitional Cell
Sites in Pittsburgh, Lancaster +60 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07218380·Phase 3·Recruiting·Listed Oct 2025
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
for Diabetes Mellitus, Type 2
Drug: Empagliflozin
Sites in Pittsburgh, Beaver +200 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT07064473·Phase 3·Recruiting·Listed Jul 2025
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
for Metastatic Castration-resistant Prostate Cancer
Sites in Pittsburgh +44 more locations
Sponsor: Amgen
Sex: Male·Age: 18+
Code: NCT07213674·Phase 3·Recruiting·Listed Oct 2025
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
for Crohn's Disease
Drug: Duvakitug
Sites in Pittsburgh, Hershey +123 more locations
Sponsor: Sanofi
Sex: All·Age: 16 - 80
Code: NCT07184931·Phase 3·Recruiting·Listed Sep 2025
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
for Cardiovascular Disease
Drug: Olpasiran
Sites in Pittsburgh, Pottstown +192 more locations
Sponsor: Amgen
Sex: All·Age: 50 - 105
Code: NCT07136012·Phase 3·Recruiting·Listed Aug 2025
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
for Breast Neoplasms
Sites in Pittsburgh +48 more locations
Sponsor: Natera, Inc.
Sex: All·Age: 18+
Code: NCT07214532·Recruiting·Listed Oct 2025
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
for Ulcerative Colitis
Drug: Duvakitug
Sites in Pittsburgh, Hershey +116 more locations
Sponsor: Sanofi
Sex: All·Age: 16 - 80
Code: NCT07184996·Phase 3·Recruiting·Listed Sep 2025
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for Triple Negative Breast Cancer
Sites in Pittsburgh, York +119 more locations
Sponsor: Gilead Sciences
Sex: All·Age: 18+
Code: NCT05633654·Phase 3·Recruiting·Listed Dec 2022
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
for Proteinuric Kidney Disease
Sites in Pittsburgh, Philadelphia +132 more locations
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All·Age: 10 - 65
Code: NCT05312879·Phase 2, Phase 3·Recruiting·Listed Apr 2022
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
for Ovarian Cancer
Drug: INCB123667
Sites in Pittsburgh, York +55 more locations
Sponsor: Incyte Corporation
Sex: Female·Age: 18+
Code: NCT07214779·Phase 3·Recruiting·Listed Oct 2025
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
for Healthy
Sites in Pittsburgh +117 more locations
Sponsor: Pfizer
Sex: All·Age: 1 Day - 49·Accepts healthy volunteers
Code: NCT07160244·Phase 3·Recruiting·Listed Sep 2025
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
for Melanoma
Sites in Pittsburgh, Hershey +89 more locations
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 18+
Code: NCT06246916·Phase 3·Recruiting·Listed Feb 2024
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
for Cervical Cancer
Sites in Pittsburgh, Monroeville +127 more locations
Sponsor: Pfizer
Sex: Female·Age: 18+
Code: NCT06952660·Phase 4·Recruiting·Listed May 2025
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
for Plaque Psoriasis
Drug: Deucravacitinib
Sites in Pittsburgh, Camp Hill +95 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 40+
Code: NCT07116967·Phase 3·Recruiting·Listed Aug 2025
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
for Early Breast Cancer
Drug: Ribociclib
Sites in Pittsburgh, Harrisburg +72 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18 - 100
Code: NCT05827081·Phase 3·Recruiting·Listed Apr 2023
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for Carcinoma, Non-Small-Cell Lung
Drug: LY3537982
Sites in Pittsburgh, Philadelphia +89 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06890598·Phase 3·Recruiting·Listed Mar 2025
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
for Advanced Non-Small Cell Lung Cancer
Drug: Adagrasib
Sites in Pittsburgh +191 more locations
Sponsor: Mirati Therapeutics Inc.
Sex: All·Age: 18+
Code: NCT04613596·Phase 2, Phase 3·Recruiting·Listed Nov 2020
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
for Colorectal Neoplasms
Drug: Amivantamab
Sites in Pittsburgh, Philadelphia +66 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT06750094·Phase 3·Recruiting·Listed Dec 2024
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
for Renal Cell Carcinoma (RCC)
Sites in Pittsburgh, Hershey +42 more locations
Sponsor: Exelixis
Sex: All·Age: 18+
Code: NCT05176483·Phase 1·Recruiting·Listed Jan 2022
REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants
for Symptomatic Venous Thromboembolism (VTE)
Drug: REGN7508
Sites in Pittsburgh +27 more locations
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 18+
Code: NCT07213778·Phase 3·Recruiting·Listed Oct 2025
Top Research Study Locations in Pittsburgh
Researchers run research studies in Pittsburgh, PA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Pittsburgh | Stroke, Traumatic Brain Injury, Dementia | 155 |
| UPMC Hillman Cancer Center | Melanoma, Metastatic Malignant Solid Neoplasm, Acute Myeloid Leukemia | 147 |
| University of Pittsburgh Medical Center | Chronic Pancreatitis, Cystic Fibrosis, Advanced Solid Tumor | 132 |
| Allegheny General Hospital | Breast Cancer, Anatomic Stage II Breast Cancer AJCC v8, Heart Failure | 64 |
| Children's Hospital of Pittsburgh of UPMC | Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Neuroblastoma | 58 |
| UPMC Children's Hospital of Pittsburgh | Fabry Disease, Cerebral Palsy, Congenital Bone Marrow Failure Syndromes | 53 |
| Allegheny Health Network | Brain Tumor, Breast Cancer, Colorectal Cancer | 33 |
| UPMC-Passavant Hospital | Anatomic Stage II Breast Cancer AJCC v8, Recurrent Endometrial Carcinoma, Stage IV Renal Cell Cancer AJCC v8 | 31 |
| UPMC-Saint Clair Hospital Cancer Center | Anatomic Stage II Breast Cancer AJCC v8, Head and Neck Squamous Cell Carcinoma, Stage III Laryngeal Cancer AJCC v8 | 26 |
| UPMC-Saint Margaret | Stage III Laryngeal Cancer AJCC v8, Stage III Lip and Oral Cavity Cancer AJCC v8, Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 | 24 |
| West Penn Hospital | Large B-cell Lymphoma, Stage IV Colorectal Cancer AJCC v8, Acute Lymphoblastic Leukemia (ALL) | 23 |
| UPMC Presbyterian | Acute Kidney Injuries, Aneurysm of Aorta, Thoracic, Aneurysmal Disease | 20 |
| UPMC-Magee Womens Hospital | Anatomic Stage II Breast Cancer AJCC v8, Recurrent Endometrial Carcinoma, Anatomic Stage I Breast Cancer AJCC v8 | 20 |
| UPMC Presbyterian Hospital | Abdominal Surgery, Acute Ischemic Stroke, Acute Myocardial Infarction | 19 |
| VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA | Cardiovascular Diseases, Stroke, Acute Kidney Injury | 19 |
| UPMC | Focal Epilepsy, ASD - Atrial Septal Defect, Advanced Melanoma | 18 |
| UPMC-Shadyside Hospital | Head and Neck Squamous Cell Carcinoma, Stage II Lip and Oral Cavity Cancer AJCC v8, Stage III Laryngeal Cancer AJCC v8 | 18 |
| University of Pittsburgh Cancer Institute (UPCI) | Head and Neck Squamous Cell Carcinoma, Metastatic Renal Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma | 16 |
| Children's Hospital of Pittsburgh | Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML or ANLL), Adolescent Congenital Heart Disease | 13 |
| University of Pittsburgh Medical Center (UPMC) | ALS, ALS (Amyotrophic Lateral Sclerosis), ALS - Amyotrophic Lateral Sclerosis | 9 |
| AHN Allegheny General Hospital | Breast Cancer, Cancer, Carcinoma, Non-Small-Cell Lung | 8 |
| AHN West Penn Hospital | Malignant Mesothelioma, Malignant Pleural Effusion, Metastasis to Pleura | 8 |
| UPMC Magee-Womens Hospital | ADHD, Behavioral Intervention, Cervical Cancer | 8 |
| University of Pittsburgh School of Medicine | Adolescents, Anorexia Nervosa, Bipolar Disorder (BD) | 8 |
| UPMC Shadyside Hospital | Abdominal Surgery, Dementia, Harm Reduction | 7 |
Active & Upcoming Studies in Pittsburgh (2026)
Recruiting trials in Pittsburgh grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (396 active studies)
- Collaborative Care Intervention for Cancer Patients and Their Family Caregivers -LITE · University of Pittsburgh
- A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information · Children's Oncology Group
Neurology & pain (81 active studies)
- Collaborative Care Intervention for Cancer Patients and Their Family Caregivers -LITE · University of Pittsburgh
- Psilocybin After Trauma Surgery for Pain · Phase 1 · Trent Emerick
Cardiovascular (74 active studies)
- TEPH: Telaglenastat Efficacy in Pulmonary Hypertension · Phase 1, Phase 2 · Chan, Stephen, MD, PhD
- Precision Analgesia for Cardiac Surgery · Kathirvel Subramaniam
Diabetes & metabolic (39 active studies)
- Technology Knowledge Optimization for Type 1 Diabetes in Schools · University of Pittsburgh
- Network-Based Support to Help Community Coalition Members Choose and Use Strategies to Improve Child Health · University of Pittsburgh
Mental health & behavior (37 active studies)
Pediatric (19 active studies)
- Hypoxic Red Blood Cells in Sickle Cell Anemia · Hemanext
- A Multicenter Study to Assess the Feasibility of 5-Aminolevulinic Acid (5-ALA) in Pediatric Brain Tumor Patients · Phase 2 · Costas Hadjipanayis
HIV / STI (8 active studies)
- Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver) · Johns Hopkins University
- Phase 1 Study of CH505 HIV Vaccine Nanoparticles and mRNA Boosters in Healthy Adults · Phase 1 · National Institute of Allergy and Infectious Diseases (NIAID)
Vaccines (7 active studies)
Eye & vision (3 active studies)
- A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults · Astellas Pharma Global Development, Inc.
- The Effect of Rinsing on Ocular Inflammation and Symptoms in Patients With Dry Eye Disease · Rinsada
Common conditions studied in Pittsburgh
- Breast Cancer (24 active studies)
- Cancer (19 active studies)
- Ovarian Cancer (17 active studies)
- Endometrial Cancer (16 active studies)
- Stroke (16 active studies)
- Melanoma (15 active studies)
Leading research sponsors in Pittsburgh
- University of Pittsburgh
- National Cancer Institute (NCI)
- AstraZeneca
- Children's Oncology Group
- VA Office of Research and Development
Frequently asked questions
How many paid clinical trials are currently recruiting in Pittsburgh?
There are approximately 1,240 recruiting clinical trials in Pittsburgh, Pennsylvania listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Pittsburgh pay participants?
Most recruiting trials in Pittsburgh compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Pittsburgh?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Pittsburgh?
The most common conditions under active study in Pittsburgh include Breast Cancer (24), Cancer (19), Ovarian Cancer (17), Endometrial Cancer (16), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Pittsburgh?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Pittsburgh on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Pittsburgh?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Pittsburgh?
Recruiting research sites in Pittsburgh include University of Pittsburgh, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Pittsburgh right now?
The largest active categories in Pittsburgh are Cancer & tumors (396), Neurology & pain (81), Cardiovascular (74). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
Browse more clinical trials
Other cities in Pennsylvania
Philadelphia, PA(1,988)Hershey, PA(268)Danville, PA(126)Allentown, PA(125)Bethlehem, PA(96)York, PA(90)Erie, PA(86)Wilkes-Barre, PA(72)Lancaster, PA(69)Monroeville, PA(63)Harrisburg, PA(56)Wynnewood, PA(52)Willow Grove, PA(46)Lewisburg, PA(45)Hazleton, PA(43)Mechanicsburg, PA(42)East Stroudsburg, PA(38)West Reading, PA(38)Greensburg, PA(34)Media, PA(34)Duncansville, PA(32)Sayre, PA(32)Dickson City, PA(30)Scranton, PA(30)Uniontown, PA(30)DuBois, PA(29)Chadds Ford, PA(28)University Park, PA(28)Chambersburg, PA(27)Lebanon, PA(26)Beaver, PA(25)Camp Hill, PA(25)West Chester, PA(24)Wyomissing, PA(24)Bala-Cynwyd, PA(23)Ephrata, PA(22)Farrell, PA(22)Gettysburg, PA(22)Plymouth Meeting, PA(22)Pottsville, PA(22)Washington, PA(22)Wexford, PA(22)Indiana, PA(21)Paoli, PA(21)Seneca, PA(21)Bryn Mawr, PA(20)Easton, PA(20)Jefferson Hills, PA(20)Johnstown, PA(20)New Castle, PA(20)State College, PA(19)Altoona, PA(18)Butler, PA(18)Smithfield, PA(18)Abington, PA(17)Cranberry Township, PA(17)Natrona Heights, PA(16)Carlisle, PA(15)Horsham, PA(15)N. Huntingdon, PA(14)